hg_69435.1

Basic information about the TSS

---

TSS ID: hg_69435.1 Species: human Chr: chr6		Start: 116571447 End: 116571452 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000487832.6 Distance: 37 GeneID: 51389 HGNC/MGI_ID: HGNC:20993 UniProt_ID: Q9H446

Gene_name: RWD domain containing 1 Gene_symbol: RWDD1 Gene_synonyms: PTD013 Gene_source: HGNC:20993

TATA-Box annotation

---

Distance to TSS:	-54
Nearest PromoterID:	NM_016104
Entrez ID:	51389
Nearest Unigene:	Hs.532164
Nearest Refseq:	NM_015952
Nearest Ensembl:	ENSG00000111832
Gene Name:	RWD domain containing 1
Gene Alias:	CGI-24|PTD013
Gene Description:	RWD domain containing 1
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.736318
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RWDD1 p2@RWDD1 p3@RWDD1 p4@RWDD1 p5@RWDD1
Sample		p1@RWDD1	p2@RWDD1	p3@RWDD1	p4@RWDD1	p5@RWDD1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	90.97	19.29	10.52	2.92	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	99.14	18.82	9.51	3.24	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	89.31	19.68	12.92	3.09	2.70
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	86.07	16.01	7.90	2.29	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	85.49	14.62	7.87	4.27	1.80
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	86.63	13.76	8.92	2.13	2.52
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	120.27	21.79	8.06	3.49	4.36
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	97.86	21.07	8.48	2.66	2.91
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	89.12	19.23	10.04	3.42	3.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	104.91	13.91	6.38	0.58	9.27
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	76.80	12.53	5.26	2.83	11.32
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	80.50	12.60	7.72	2.03	12.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	89.95	15.31	2.42	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	75.63	13.83	2.41	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	75.75	13.61	3.29	1.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	68.91	12.07	2.26	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	70.55	13.98	2.84	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	67.49	16.87	2.95	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	83.17	11.20	1.60	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	103.65	15.65	3.16	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	78.59	12.30	3.34	1.07	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	90.80	14.16	2.42	2.07	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	73.16	13.05	2.46	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	66.01	11.41	2.91	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	93.13	12.90	5.93	1.55	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	84.51	17.09	4.43	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	82.97	12.64	4.95	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	95.48	14.38	1.89	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	94.17	14.05	3.55	1.29	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	81.98	14.66	2.90	0.72	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	90.23	14.65	3.56	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	97.89	13.29	3.91	1.76	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	80.40	15.83	5.49	1.27	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	91.21	14.02	3.96	0.66	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	80.22	16.83	3.55	0.93	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	80.10	16.29	3.26	1.53	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	82.98	13.08	3.68	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	68.71	10.07	2.22	0.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	86.97	16.21	2.43	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	83.78	15.84	4.80	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	68.23	12.23	4.47	1.41	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	82.86	12.59	3.81	0.88	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	76.55	17.08	4.01	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	93.01	15.38	4.20	1.75	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	85.13	16.06	2.61	1.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	89.80	16.29	6.05	1.40	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	79.65	16.79	5.04	2.40	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	104.02	13.71	5.96	1.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	75.64	15.08	6.22	1.91	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	101.91	19.61	4.65	1.01	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	96.33	13.73	4.92	2.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	112.74	16.90	5.78	1.78	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	279.84	83.95	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	66.71	15.61	4.97	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	63.29	12.59	4.31	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	92.28	7.55	3.36	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	98.28	12.40	3.67	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	62.88	12.96	2.92	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	56.85	12.20	2.89	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	120.39	10.69	3.77	0.94	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	55.70	11.28	2.82	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	56.64	12.34	0.56	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	101.91	9.55	3.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	98.19	7.81	4.76	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	55.56	11.05	3.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	51.12	16.33	1.77	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	226.30	32.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	165.85	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	46.80	17.06	2.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	56.03	20.83	3.47	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	40.34	17.83	1.41	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	72.20	13.58	2.32	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	47.02	16.40	4.64	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	57.17	16.20	3.36	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	69.06	8.71	6.18	1.58	0.95
Adipocyte - breast, donor2	11327-117E4	71.71	5.45	4.33	0.80	0.80
Adipocyte - omental, donor1	11473-119C6	71.63	7.76	6.11	0.64	1.02
Adipocyte - omental, donor2	11474-119C7	76.24	8.97	6.73	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	90.76	6.70	6.36	1.34	0.00
Adipocyte - perirenal, donor1	11476-119C9	42.75	6.38	3.83	0.64	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	29.69	5.50	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	47.42	6.32	2.71	1.81	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	66.21	3.30	2.09	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	68.84	11.54	5.08	2.35	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	45.81	7.72	3.09	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	53.52	10.31	5.58	2.23	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	58.19	7.64	5.29	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	108.83	9.33	9.73	2.73	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	61.32	9.68	3.87	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	53.85	5.87	5.87	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	54.53	3.34	5.56	1.67	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	61.55	4.99	4.99	1.66	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	54.00	8.29	3.27	1.26	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	55.63	4.58	5.24	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	49.02	4.26	4.57	1.22	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	36.69	15.69	3.54	0.88	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	6.45	4.30	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	2.40	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	19.43	11.51	1.08	0.72	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	10.04	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	23.01	9.45	2.47	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	84.22	8.01	2.75	0.57	0.00
Anulus Pulposus Cell, donor2	11463-119B5	72.49	5.63	1.22	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	26.51	7.19	3.59	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	30.82	9.55	3.47	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	44.95	14.98	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	34.08	6.28	1.49	0.60	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	54.38	15.18	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	38.28	2.64	1.98	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.99	6.17	2.92	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	31.55	8.25	1.94	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	33.85	5.94	2.97	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	35.40	4.90	3.77	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	28.30	8.71	1.45	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	26.33	12.54	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	44.64	6.92	2.31	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	23.20	8.19	2.73	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	43.43	8.44	3.02	1.06	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.00	6.97	1.61	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	35.90	8.50	4.16	1.13	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	31.27	7.48	2.67	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	18.53	7.80	0.98	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	42.13	7.30	3.32	1.00	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	20.41	10.81	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	7.08	3.54	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	40.31	11.66	4.46	0.69	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	37.75	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	25.73	8.74	1.46	1.94	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	53.12	8.73	5.69	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	39.98	3.63	2.42	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	35.91	6.27	2.85	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	41.69	5.13	2.57	1.28	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	35.87	8.00	3.61	1.03	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	33.78	7.51	2.82	2.35	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	34.73	5.79	5.79	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.97	3.57	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.17	8.19	2.92	1.17	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	37.63	6.62	2.41	0.90	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	46.33	8.32	4.75	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	25.94	3.05	3.56	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	41.00	6.37	2.04	1.27	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	31.77	3.81	4.45	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	32.80	7.34	3.02	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	37.47	10.16	5.08	1.48	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	34.22	5.80	3.19	0.87	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	36.84	9.45	5.67	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	40.69	8.31	3.39	0.68	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	2.32	4.63	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	6.34	6.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	40.31	8.15	2.36	1.07	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	36.70	4.21	5.41	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	5.10	2.92	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	45.75	8.51	2.76	0.92	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	2.55	2.55	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	43.73	8.14	4.07	1.27	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	44.38	7.64	3.10	1.45	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	31.52	4.28	3.67	1.53	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	28.68	8.60	1.91	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	39.91	7.10	2.88	0.89	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	4.58	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	28.25	4.98	1.11	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	41.31	8.74	2.91	1.59	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	42.52	8.72	2.18	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	37.70	17.19	3.93	1.84	0.12
Astrocyte - cerebellum, donor2	11580-120F5	26.36	8.04	0.68	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	11.12	7.97	1.05	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	68.67	17.43	3.83	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	63.74	15.69	3.56	0.97	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	73.54	15.96	3.28	0.89	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	93.12	23.63	2.29	1.95	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	111.75	29.57	5.76	1.50	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	103.78	29.70	4.10	2.28	0.57
Basophils, donor1	12241-129G9	31.91	24.32	3.14	0.78	0.00
Basophils, donor2	12242-129H1	108.96	27.06	2.53	1.08	1.08
Basophils, donor3	12243-129H2	60.86	23.37	3.38	2.35	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	16.17	4.74	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	2.74	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	34.52	15.06	3.77	1.88	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	13.52	3.95	1.25	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	17.50	7.60	0.69	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	43.91	9.18	2.70	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	100.48	8.24	3.71	1.13	3.19
Burkitt's lymphoma cell line:RAJI	10476-106I8	165.36	23.06	6.99	1.86	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	77.07	13.75	3.20	1.60	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	62.05	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	51.28	15.22	2.82	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	47.88	17.08	3.16	0.37	0.56
CD14+ Monocytes, donor3	11381-118B4	43.91	14.71	2.63	0.44	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	63.97	10.19	3.11	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	63.68	15.54	1.90	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	66.73	14.46	2.30	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	26.45	4.48	1.59	0.87	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	31.08	3.92	1.21	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	29.14	5.21	1.90	0.00	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	18.75	3.01	0.67	0.50	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	26.77	3.86	1.93	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	21.07	6.69	1.74	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	21.15	7.05	1.96	0.59	1.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	28.31	6.23	1.42	0.18	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	45.05	16.76	3.05	1.09	3.26
CD14+ monocytes - treated with Candida, donor1	11868-125B5	26.22	3.75	1.40	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	35.91	7.39	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	11.09	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.01	3.72	0.89	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	30.53	3.39	0.80	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	35.39	7.50	1.46	0.21	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	19.45	3.89	0.00	0.23	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	32.35	6.79	1.13	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	21.82	3.06	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	24.21	8.61	2.69	1.08	2.42
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	43.44	10.82	2.09	0.87	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	51.76	15.57	4.63	0.42	4.63
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	16.72	3.86	1.47	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	16.20	5.28	0.35	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.99	4.83	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	22.49	5.75	1.57	0.35	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	36.80	6.69	2.23	0.37	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	52.81	15.09	1.94	1.08	3.88
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	21.70	2.46	0.82	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	26.19	6.72	0.23	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	23.90	5.80	0.70	0.23	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	52.09	18.53	2.83	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	44.35	13.63	2.31	1.39	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	53.29	21.88	1.73	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	48.12	12.30	2.18	0.78	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	45.58	14.50	2.62	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	74.92	16.28	5.13	0.67	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	47.46	19.14	3.06	1.28	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	42.60	16.91	1.54	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	53.90	22.32	3.79	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	99.58	22.36	6.10	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	77.97	21.02	2.03	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	82.85	14.50	3.11	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	86.89	22.92	1.60	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	83.63	30.56	2.68	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	71.60	18.25	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	55.69	24.31	3.92	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	67.23	19.77	3.95	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	44.38	29.59	2.47	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	44.98	30.47	2.18	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	40.39	30.79	3.03	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	88.49	54.55	6.87	3.64	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	59.92	52.33	6.79	3.99	1.60
CD34+ Progenitors, donor1	11545-120B6	58.23	14.06	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	85.96	23.60	2.81	1.12	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	77.78	13.15	1.50	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	86.36	16.91	3.83	0.90	0.68
CD4+ T Cells, donor1	11225-116C1	150.68	74.62	3.57	1.07	2.14
CD4+ T Cells, donor2	11306-117C1	108.39	61.24	5.51	1.84	1.84
CD4+ T Cells, donor3	11382-118B5	112.24	44.22	2.44	0.30	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	56.15	33.44	2.55	0.77	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	79.51	32.34	4.27	2.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	60.65	37.66	2.59	1.44	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	82.49	49.78	2.84	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	123.61	49.16	3.51	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	29.67	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	59.97	20.52	2.31	0.87	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	52.53	27.79	4.74	1.02	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	47.07	24.50	2.74	0.64	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	72.18	41.69	5.38	0.90	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	114.25	42.28	3.49	1.40	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	104.28	53.68	4.84	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	67.04	33.31	2.53	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	63.79	18.70	2.49	1.25	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	52.79	25.39	4.34	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	95.18	42.97	2.99	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	142.56	50.38	1.61	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	77.11	41.24	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	86.78	27.81	3.34	1.48	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	76.25	29.89	3.25	0.65	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	61.36	30.26	4.62	1.05	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	102.13	41.97	2.02	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	117.84	35.96	3.03	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	131.62	47.94	4.36	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	143.51	41.57	4.95	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	111.71	28.62	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	86.54	37.69	4.19	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	164.77	42.65	4.15	1.11	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	189.93	46.87	4.66	0.74	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	133.98	23.10	9.24	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	114.24	26.50	5.37	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	110.80	27.70	4.15	6.92	0.00
CD8+ T Cells, donor1	11226-116C2	129.32	51.40	4.26	0.65	2.62
CD8+ T Cells, donor2	11307-117C2	107.37	37.54	3.75	0.38	1.88
CD8+ T Cells, donor3	11383-118B6	128.26	49.74	4.54	1.01	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	34.64	11.93	3.67	1.15	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	36.19	8.87	1.92	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	36.66	10.67	2.19	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	39.93	9.61	1.80	0.00	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	36.24	11.28	3.84	1.20	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	36.61	10.91	3.41	0.68	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	34.98	11.52	1.74	1.52	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	33.16	10.53	5.00	1.05	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	43.15	10.79	3.05	1.88	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	44.07	9.36	3.32	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	44.74	8.72	2.32	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	43.16	6.39	4.53	1.07	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	26.27	3.06	1.31	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	30.97	5.47	2.73	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.88	5.22	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	30.61	10.44	2.52	1.08	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	39.13	8.63	2.30	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	32.05	10.84	3.06	0.71	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	40.25	10.77	4.75	2.85	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	38.75	9.23	4.31	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.66	9.94	6.09	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	43.22	10.71	3.82	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	29.56	8.67	4.34	0.39	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	39.33	4.54	2.27	3.03	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	39.34	4.01	4.82	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	44.06	4.90	3.50	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	38.07	8.01	6.01	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	21.93	1.83	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	39.53	8.89	3.95	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	46.62	9.26	2.95	1.05	0.11
Chondrocyte - de diff, donor1	11261-116G1	74.19	18.03	6.93	0.35	1.04
Chondrocyte - de diff, donor2	11338-117F6	40.51	4.62	1.78	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	73.27	7.17	3.07	0.91	0.34
Chondrocyte - re diff, donor2	11339-117F7	79.68	20.59	6.27	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	55.40	7.28	3.64	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	69.43	19.74	3.79	1.15	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	42.54	13.47	2.35	1.28	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	53.63	16.11	3.36	0.88	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	28.34	13.30	2.02	0.92	0.00
Corneal Epithelial Cells, donor1	11526-119I5	8.34	7.25	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	18.20	4.55	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	13.55	9.20	1.53	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	42.43	8.09	1.49	0.83	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	35.96	6.62	2.52	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	82.82	6.90	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	40.82	5.62	2.48	0.43	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	90.19	18.45	2.73	1.71	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	112.95	20.89	5.22	2.61	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	122.44	32.91	3.39	1.45	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	20.01	8.17	1.67	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	15.84	14.08	2.35	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	23.75	14.14	3.39	1.13	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	29.10	9.04	2.75	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	14.83	11.63	2.04	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	32.94	9.88	3.29	1.18	0.47
Endothelial Cells - Artery, donor3	11413-118E9	26.82	14.02	1.40	0.70	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.44	10.42	1.55	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	40.16	18.86	2.43	1.83	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	39.18	16.35	2.82	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	27.34	10.99	2.97	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	31.76	16.66	1.04	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	18.72	4.82	1.28	0.71	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	58.02	33.61	4.80	2.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	12.05	6.29	1.05	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	90.45	29.69	5.34	1.49	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	63.66	22.16	4.13	2.61	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	71.93	26.26	4.52	1.47	0.24
Endothelial Cells - Vein, donor1	11267-116G7	12.51	7.96	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.07	9.08	2.79	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	33.76	10.83	1.26	0.47	0.00
Eosinophils, donor1	12244-129H3	198.21	30.49	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	19.80	8.25	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	24.97	10.70	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	17.84	7.82	1.47	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	82.51	13.96	5.34	1.64	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	48.28	9.09	3.61	1.97	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	74.54	23.73	6.18	2.38	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	61.85	10.31	3.27	1.09	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	15.97	5.87	1.36	0.82	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	51.89	8.54	4.32	0.84	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.28	4.22	0.79	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	51.82	20.26	3.32	1.99	0.33
Fibroblast - Cardiac, donor1	11268-116G8	27.67	7.71	2.27	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	13.64	6.06	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	26.34	5.68	1.89	0.32	0.47
Fibroblast - Cardiac, donor4	11452-119A3	85.78	14.55	4.24	1.82	0.30
Fibroblast - Cardiac, donor5	11456-119A7	53.68	12.44	3.81	1.14	0.13
Fibroblast - Cardiac, donor6	11460-119B2	53.66	15.46	3.64	1.67	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	32.69	13.53	3.08	0.80	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	38.40	12.08	2.16	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	36.62	13.18	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	26.98	15.22	3.69	2.08	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	93.45	5.94	2.88	0.85	0.34
Fibroblast - Dermal, donor1	11269-116G9	59.16	12.91	5.40	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	30.19	15.57	4.72	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	86.43	12.33	3.51	1.33	0.00
Fibroblast - Dermal, donor4	11450-119A1	86.48	24.64	6.10	1.36	0.34
Fibroblast - Dermal, donor5	11454-119A5	92.46	24.77	6.45	0.70	0.52
Fibroblast - Dermal, donor6	11458-119A9	117.92	30.05	5.52	2.27	0.32
Fibroblast - Gingival, donor1	11237-116D4	102.87	15.20	6.25	1.46	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	93.53	16.24	7.60	1.57	0.00
Fibroblast - Gingival, donor2	11318-117D4	79.60	21.61	3.03	1.05	0.40
Fibroblast - Gingival, donor3	11394-118C8	103.26	11.99	4.45	0.77	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	81.03	11.43	4.16	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	58.15	8.63	2.82	1.23	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	101.33	20.73	9.04	2.81	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	109.40	17.17	7.57	2.16	1.62
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	81.87	19.41	7.06	3.18	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	112.61	17.99	7.60	2.34	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	93.54	15.95	7.36	1.09	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	118.58	35.32	13.05	5.27	2.08
Fibroblast - Gingival, donor9 (control)	11927-125I1	108.15	14.09	3.08	1.03	0.29
Fibroblast - Lung, donor1	11270-116H1	12.23	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	62.67	14.92	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	43.90	7.39	1.90	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	28.32	22.49	4.17	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	55.95	11.19	4.20	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.40	5.32	0.84	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	63.33	24.36	5.68	1.62	0.81
Fibroblast - Mammary, donor2	11620-122A9	19.97	11.98	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	95.82	29.29	4.85	2.52	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	108.30	30.94	7.89	2.58	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	109.54	28.46	5.51	2.75	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	82.05	21.37	6.11	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	68.85	11.88	4.59	1.62	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	65.76	9.74	4.64	0.93	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	53.94	15.70	3.21	1.33	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	32.10	18.49	2.44	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.05	17.37	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	66.42	13.05	3.56	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	24.41	5.75	2.78	0.60	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	78.51	12.26	2.31	1.24	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	81.79	14.19	5.72	2.17	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.65	4.81	1.81	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	101.80	13.60	5.94	0.65	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.76	4.56	1.01	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	78.59	12.14	3.94	1.48	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	25.66	8.02	2.41	1.20	1.20
Fibroblast - skin normal, donor2	11561-120D4	79.16	15.27	6.13	1.61	1.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	19.04	5.74	2.42	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	88.48	8.12	4.31	1.49	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	115.22	11.97	3.76	1.54	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	14.78	6.24	1.97	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	85.11	18.75	7.35	0.96	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	52.12	15.69	5.23	1.86	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	116.36	8.47	5.18	2.20	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	398.88	22.16	22.16	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	75.82	4.36	6.10	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	57.38	10.40	3.81	0.52	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	63.24	12.75	5.47	1.30	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	60.81	16.10	4.60	2.04	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	34.45	27.56	9.19	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	34.46	23.61	6.38	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	89.57	37.94	5.42	2.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	73.90	19.03	1.93	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	49.32	16.67	3.20	1.60	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	60.63	26.35	4.56	2.18	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	58.68	16.92	4.23	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	55.44	20.22	5.22	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	78.72	27.86	5.75	2.65	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	48.05	12.44	2.54	0.57	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	46.92	10.84	3.32	1.35	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	50.50	15.31	4.30	1.88	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	57.11	11.40	3.59	1.36	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	53.29	10.66	3.32	1.25	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	38.22	14.03	4.68	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	54.76	12.78	5.48	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	50.82	11.09	2.62	0.62	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	52.02	12.68	3.72	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	70.62	14.77	2.66	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	50.23	13.67	2.07	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	52.73	15.19	3.35	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	68.35	8.07	1.81	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	58.53	10.35	1.70	1.02	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	69.78	14.54	4.52	1.15	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	88.76	14.36	3.23	0.42	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	82.48	18.96	2.90	0.85	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	63.52	11.07	2.43	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	70.38	12.48	3.33	1.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	60.85	15.72	2.65	0.82	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	74.68	10.52	3.30	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	67.68	10.03	1.50	0.46	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	59.03	9.51	2.00	0.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	73.18	10.36	2.65	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	74.04	11.81	2.34	0.61	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	56.41	11.18	2.43	0.81	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	88.52	16.36	1.28	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	53.25	8.62	1.99	0.76	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	60.27	8.54	2.53	0.95	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	56.26	12.77	1.22	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	55.09	7.63	1.67	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	65.21	6.37	2.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	53.30	9.54	2.52	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	52.40	10.00	1.76	0.83	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	65.25	12.84	1.87	1.34	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	60.59	13.31	4.44	0.77	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	49.87	9.72	4.15	1.04	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	76.98	10.03	2.98	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	68.21	7.37	2.77	0.55	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	74.79	8.33	1.75	2.63	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	82.31	15.87	6.94	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	73.48	13.98	3.03	1.45	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	70.82	9.28	3.63	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	102.68	15.50	4.57	1.78	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	72.86	26.47	4.98	2.39	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	48.84	14.95	3.08	0.46	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	54.01	18.21	3.07	1.23	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	62.90	22.84	5.63	1.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	51.71	28.82	5.37	3.67	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	38.28	25.37	3.69	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	74.24	24.75	7.42	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	56.86	23.60	4.64	2.32	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	49.74	6.42	4.81	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	33.04	13.91	5.22	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	61.84	24.41	7.16	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	56.42	21.41	6.18	2.47	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	13.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	58.73	19.85	5.03	1.12	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	59.49	19.28	5.56	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	40.26	20.97	5.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.39	22.90	4.77	1.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	57.74	14.61	3.74	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	77.26	29.23	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	57.84	19.47	7.45	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	44.69	11.84	3.55	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	55.91	25.41	6.78	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	62.96	19.05	3.31	2.90	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	55.69	19.79	4.60	0.92	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	126.44	21.07	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	51.13	14.99	3.84	1.92	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	73.02	17.28	6.19	2.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	113.70	16.72	4.01	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	71.66	15.03	2.70	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	69.49	17.12	3.77	2.40	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	29.82	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	100.03	19.82	2.36	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	62.76	17.50	6.03	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	88.51	22.38	4.07	1.53	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	81.36	17.55	2.79	1.20	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	85.35	23.19	1.48	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	64.92	11.80	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	83.43	16.34	5.25	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	89.97	19.31	5.27	1.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	55.10	11.02	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.72	10.74	1.79	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	57.26	12.62	4.37	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	4.57	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	27.86	5.41	2.49	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	14.62	4.50	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	56.45	4.76	1.59	1.27	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	55.56	7.94	0.84	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	47.23	18.22	6.03	1.97	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	44.73	21.44	4.90	2.36	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	43.91	24.80	4.78	2.50	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	41.21	21.10	4.37	2.19	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	44.49	18.70	5.80	3.87	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	41.33	23.04	6.46	1.72	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	50.06	17.19	5.73	2.24	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	47.18	16.30	5.66	2.06	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	39.09	20.50	3.52	1.92	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	26.86	11.75	2.24	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.12	8.22	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	10.58	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	23.63	12.70	1.76	0.71	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	4.36	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	37.77	15.56	2.97	0.17	0.52
Hepatocyte, donor1	11523-119I2	64.16	8.47	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	57.10	2.15	6.46	2.15	3.23
Hepatocyte, donor3	11684-122I1	40.49	7.36	3.68	1.23	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	52.21	24.15	3.26	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	55.76	19.75	3.50	1.40	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	50.90	11.39	2.74	1.51	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	6.92	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	12.99	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	3.33	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	10.59	5.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	7.76	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.71	2.52	0.63	0.63	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	7.73	1.55	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	10.34	5.17	1.29	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	4.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.15	4.89	0.81	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.14	3.78	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.90	4.82	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	5.54	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	4.72	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	2.72	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	7.53	2.15	2.15	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	16.52	5.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.75	5.74	1.91	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	7.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.14	6.43	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.36	6.79	0.93	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.04	5.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	8.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	10.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	8.53	3.20	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	4.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.97	8.28	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	13.75	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	36.56	9.38	3.67	1.22	0.24
Keratinocyte - epidermal, donor2	11349-117G8	14.06	5.27	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	73.17	22.43	3.88	0.95	0.00
Keratinocyte - oral, donor1	11251-116E9	89.00	15.78	2.84	0.23	0.23
Keratocytes, donor1	11527-119I6	16.85	12.72	2.06	0.34	0.00
Keratocytes, donor2	11607-120I5	19.92	8.20	3.52	0.00	0.00
Keratocytes, donor3	11688-122I5	42.29	7.51	1.78	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	46.16	21.98	4.40	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	29.13	7.55	3.24	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	63.55	13.61	2.19	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	53.99	16.25	3.63	2.72	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	25.26	10.91	2.73	1.07	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	24.84	7.54	1.95	1.67	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	30.07	8.97	2.83	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.74	9.14	2.15	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	30.57	6.93	0.95	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.02	6.15	1.73	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	26.27	6.98	1.23	1.23	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.14	7.08	1.26	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	19.00	6.76	1.41	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	24.92	4.75	2.37	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.28	9.69	1.94	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.55	4.07	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	30.31	10.10	1.39	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	24.09	6.44	2.39	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.48	4.12	1.79	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	26.18	9.55	1.23	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	11.53	6.23	1.87	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	14.09	5.86	0.91	0.73	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	23.37	6.25	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.69	4.10	1.76	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.46	2.24	0.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.76	9.70	1.94	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	27.20	9.69	2.69	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	17.71	5.00	1.51	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	21.77	7.26	4.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.43	10.47	2.30	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	14.29	4.81	0.45	0.60	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	35.77	8.25	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	21.45	9.03	1.13	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.51	4.45	1.17	1.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	29.07	7.27	4.36	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	18.19	6.62	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	13.38	5.95	0.87	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	31.84	10.74	2.59	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	26.68	8.40	2.96	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	12.79	4.40	0.96	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	34.74	10.29	1.93	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	29.52	8.83	3.04	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	26.59	7.42	3.08	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	21.69	11.73	2.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	16.97	2.91	1.94	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.58	3.73	0.78	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	29.72	5.37	2.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	18.29	7.84	1.63	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.06	4.00	0.71	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.74	8.91	2.72	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.11	5.89	1.54	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	16.11	9.25	2.69	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	6.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.14	5.37	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	4.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	5.92	3.81	0.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	6.33	2.81	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	1.87	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.76	5.15	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	2.38	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	8.37	5.43	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	14.54	8.43	2.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.76	10.80	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	7.05	6.37	0.41	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.68	4.11	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	10.23	3.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	6.66	2.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	7.64	4.58	1.02	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.74	10.41	0.27	1.07	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	18.33	8.50	1.51	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.91	6.14	1.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	11.42	7.34	0.00	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	20.41	8.54	1.25	0.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	20.74	11.77	1.12	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	3.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	16.26	8.71	1.45	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.44	6.58	1.79	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	19.92	9.41	1.66	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	8.48	5.30	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.80	5.53	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	6.14	3.84	0.77	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.19	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	13.13	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.87	1.81	1.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.18	5.03	0.72	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	19.42	11.20	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	5.95	3.34	0.37	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.49	6.03	1.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.13	5.14	1.71	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.00	4.00	1.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	4.83	4.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	6.40	7.11	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.94	2.06	0.34	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.05	4.83	0.00	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.10	5.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	8.15	3.70	0.74	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	5.81	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	3.17	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	7.60	4.80	0.80	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.00	2.18	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	5.37	5.37	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	7.40	0.99	0.49	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	2.82	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	4.53	3.52	0.00	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	3.15	4.06	0.90	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.02	5.34	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	4.30	0.78	1.17	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.28	4.62	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	8.30	3.63	1.04	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	4.38	5.25	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.95	5.59	1.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	6.18	4.86	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	9.64	6.56	0.39	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	8.61	2.53	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	7.69	2.40	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	6.36	4.77	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	11.54	3.65	1.22	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.23	3.46	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.64	6.46	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.26	3.10	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.26	6.05	1.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.24	5.07	1.58	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	5.33	3.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.05	5.17	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	6.17	2.57	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.95	3.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.65	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	7.90	5.41	0.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	5.48	7.83	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	6.26	3.76	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	4.65	4.18	0.93	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	4.68	3.35	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	5.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.49	2.83	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	6.42	3.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	4.45	2.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.98	7.98	0.57	1.14	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.90	5.37	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.21	5.47	1.09	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	4.45	4.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	6.24	4.94	0.26	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	7.29	7.96	1.33	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	2.08	2.08	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	38.06	9.12	0.46	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	38.17	11.93	3.85	1.10	0.37
Macrophage - monocyte derived, donor3	11389-118C3	34.61	8.78	2.62	0.79	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	70.09	11.15	4.25	2.12	2.12
Mallassez-derived cells, donor2	11929-125I3	85.25	15.53	6.65	1.27	0.79
Mallassez-derived cells, donor3	11930-125I4	105.77	16.26	7.78	1.39	0.56
Mammary Epithelial Cell, donor1	11273-116H4	91.17	20.23	5.08	2.19	1.30
Mammary Epithelial Cell, donor2	11350-117G9	81.36	18.24	5.50	3.19	0.58
Mammary Epithelial Cell, donor3	11422-118F9	25.19	4.74	1.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	109.83	52.20	11.52	0.00	0.68
Mast cell, donor1	11563-120D6	51.04	32.66	3.14	1.08	0.32
Mast cell, donor2	11565-120D8	43.98	25.56	1.78	0.59	1.19
Mast cell, donor3	11566-120D9	53.58	32.87	1.58	0.68	0.00
Mast cell, donor4	11567-120E1	44.32	21.98	1.24	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	72.63	24.29	3.33	1.00	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	58.95	22.76	2.33	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	45.66	21.68	2.52	0.46	0.23
Mast cell, expanded, donor8	11941-126A6	55.73	16.74	4.02	0.67	0.00
Melanocyte - dark, donor1	11502-119F8	97.01	15.22	6.77	2.39	1.49
Melanocyte - dark, donor2	11582-120F7	42.57	6.23	1.38	0.69	1.38
Melanocyte - dark, donor3	11663-122F7	75.48	21.51	2.83	1.01	0.36
Melanocyte - light, donor1	11274-116H5	14.34	6.11	1.41	0.00	0.00
Melanocyte - light, donor2	11351-117H1	12.28	2.05	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.88	1.73	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	54.35	20.62	2.92	0.83	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	51.37	15.60	4.57	1.08	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	94.02	17.95	5.36	2.41	0.27
Meningeal Cells, donor1	11493-119E8	55.08	31.88	4.84	0.87	0.00
Meningeal Cells, donor2	11573-120E7	60.30	17.61	6.16	0.00	0.00
Meningeal Cells, donor3	11654-122E7	73.03	24.69	4.48	0.82	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	82.70	22.81	5.42	1.71	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	46.89	12.58	4.23	1.11	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	5.26	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	11.77	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	48.80	14.35	3.59	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	55.48	13.34	4.24	1.27	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	53.28	13.07	1.01	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	26.81	18.90	2.64	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	35.07	15.34	4.38	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	18.21	10.64	3.07	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	91.55	10.11	2.91	0.69	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.18	3.72	1.12	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	71.31	10.00	3.42	1.32	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	18.69	2.37	0.59	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	28.82	10.89	1.92	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	67.70	17.37	4.25	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	76.62	8.44	2.81	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	43.54	14.51	3.63	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	48.00	10.61	3.71	1.33	0.80
Mesothelial Cells, donor2	12156-128G5	42.54	8.51	6.51	1.00	0.50
Mesothelial Cells, donor3	11402-118D7	30.93	10.55	3.76	0.87	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	39.16	16.20	8.10	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	45.31	13.05	3.20	0.99	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.69	11.48	4.42	1.18	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	38.12	7.75	2.17	1.55	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	29.46	9.33	3.32	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	4.63	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	40.54	12.26	2.75	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	33.98	13.03	2.79	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	39.22	7.72	2.44	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.13	10.30	5.15	1.58	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	28.32	3.54	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	33.81	9.88	1.90	1.52	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	1.32	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.98	7.85	1.27	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	17.50	7.37	4.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.48	6.86	1.19	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	8.38	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	28.60	8.53	3.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.53	8.56	2.14	1.19	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.72	5.53	1.11	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	28.09	6.68	2.07	0.69	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	31.97	8.62	1.68	0.63	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	30.98	8.97	2.65	0.41	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	30.46	7.72	1.50	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	29.56	8.45	2.67	0.67	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	26.28	7.67	2.63	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	26.36	10.14	3.55	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	13.26	4.97	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	33.70	11.14	4.35	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	31.76	14.12	1.76	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	7.63	6.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	21.14	6.73	2.40	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	31.62	12.81	4.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	13.71	5.48	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	31.04	15.52	3.00	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	16.31	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	32.84	14.89	4.38	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	9.93	4.41	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.98	8.97	3.84	1.28	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	36.69	17.35	4.46	2.48	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	25.05	12.53	5.57	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	4.42	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	27.35	6.84	4.79	2.39	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.94	11.38	4.81	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	14.91	6.75	2.13	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	28.90	10.38	2.81	1.96	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	27.02	11.22	6.23	1.25	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.73	4.66	1.17	0.58	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.32	9.95	3.02	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	29.63	12.94	5.01	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	1.85	2.77	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	34.72	10.81	6.83	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	22.66	6.36	2.90	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	24.62	7.26	2.07	0.78	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	32.60	9.44	5.58	2.14	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.97	5.08	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	21.88	7.47	4.54	1.07	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	35.32	8.98	2.69	2.10	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.94	6.36	2.26	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.11	8.92	3.82	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	31.62	11.94	6.86	1.99	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.06	6.07	4.55	0.76	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	26.71	6.53	1.14	1.14	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.53	7.13	3.93	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	16.29	0.65	1.96	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.99	7.94	2.35	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	33.73	8.94	3.46	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	28.03	10.30	5.36	1.24	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	22.93	7.15	2.38	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	5.35	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	42.39	10.84	3.29	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	33.66	3.16	2.10	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	36.18	10.08	2.97	1.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	41.91	18.63	2.79	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	44.31	12.39	3.00	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	30.10	12.25	2.13	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	33.93	8.14	1.58	0.45	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	23.58	7.37	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	39.94	15.02	2.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	10.89	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	54.51	16.03	2.67	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	15.46	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	25.25	6.06	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	39.21	12.65	2.11	1.69	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	69.46	13.62	5.45	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	78.84	11.44	2.54	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	86.65	21.06	2.43	0.81	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	66.46	16.61	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	11.42	5.71	5.71	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	110.92	42.41	9.79	6.52	16.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	4.75	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	56.23	14.00	4.52	0.43	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	59.58	12.02	2.09	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	64.75	10.68	6.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	58.85	14.19	5.43	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	163.52	14.64	3.99	2.09	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	103.73	28.73	7.98	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	42.84	8.84	7.48	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	101.07	9.19	7.35	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	67.38	6.28	3.35	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	87.86	17.20	4.88	1.16	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	82.15	10.00	2.97	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	53.19	9.25	3.78	1.68	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	200.42	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	81.90	9.43	7.45	1.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	132.63	5.68	3.52	1.62	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	62.79	6.80	4.31	1.59	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	79.85	5.39	1.63	0.33	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	65.79	4.19	4.74	0.36	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	60.47	6.37	2.12	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	62.43	7.20	4.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	206.75	5.58	2.63	0.98	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	81.80	6.83	2.28	0.65	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	83.43	8.29	4.76	0.71	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	54.85	7.74	2.11	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	94.24	5.98	5.06	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	93.19	7.39	4.18	1.93	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	234.18	5.17	3.10	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	189.63	20.23	15.17	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	74.41	7.80	5.12	2.01	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	55.04	8.89	4.23	1.27	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	111.79	5.93	4.75	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	84.99	9.01	3.43	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	379.17	9.03	9.03	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	108.30	7.66	6.00	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	46.44	8.12	1.80	0.00	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	43.25	7.94	5.16	1.98	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	68.72	9.29	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	138.11	6.43	4.54	2.27	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	72.02	10.75	3.91	1.30	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	88.90	10.46	2.18	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	77.79	9.95	7.24	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	64.38	11.46	3.53	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	89.09	4.65	2.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	99.70	7.44	4.96	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	75.42	8.04	4.59	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	87.10	6.05	3.63	1.21	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	55.70	7.96	3.32	1.33	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	56.25	14.91	4.74	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	224.82	5.11	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	116.45	8.54	4.27	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	97.57	12.90	5.98	1.26	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	113.49	8.47	3.93	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	77.53	7.12	4.75	3.96	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	114.50	10.20	4.53	4.53	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	242.78	10.12	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	60.25	9.57	4.47	1.74	1.37
Myoblast, donor2	11322-117D8	68.08	8.06	2.49	1.53	0.19
Myoblast, donor3	11398-118D3	73.66	12.78	5.55	1.51	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	72.82	9.92	1.61	1.17	2.19
Natural Killer Cells, donor1	11230-116C6	127.00	43.36	5.23	1.54	2.46
Natural Killer Cells, donor2	11311-117C6	103.13	32.57	3.02	1.51	2.41
Natural Killer Cells, donor3	11387-118C1	100.49	32.21	2.76	1.47	1.29
Neural stem cells, donor1	11275-116H6	76.58	13.79	6.53	0.73	0.36
Neural stem cells, donor2	11352-117H2	84.73	38.51	3.85	0.00	0.00
Neurons, donor1	11494-119E9	56.89	17.07	4.55	2.28	0.00
Neurons, donor2	11574-120E8	59.66	12.33	2.64	0.88	0.44
Neurons, donor3	11655-122E8	79.75	28.78	5.76	0.00	0.00
Neutrophils, donor1	11233-116C9	9.28	0.93	0.93	0.93	0.00
Neutrophils, donor2	11314-117C9	11.60	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	19.55	6.11	1.83	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	81.69	7.60	2.26	0.47	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	54.70	4.88	1.63	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	74.20	10.03	3.41	0.80	0.00
Olfactory epithelial cells, donor1	11933-125I7	66.62	9.09	2.34	0.69	0.14
Olfactory epithelial cells, donor2	11934-125I8	74.98	11.72	5.07	2.32	0.29
Olfactory epithelial cells, donor3	11935-125I9	80.70	9.31	4.77	2.04	0.11
Olfactory epithelial cells, donor4	11936-126A1	76.55	11.98	4.19	0.97	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	53.56	18.66	4.21	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	32.75	8.30	2.98	1.28	0.21
Osteoblast - differentiated, donor2	11353-117H3	22.86	6.86	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	63.93	6.21	3.72	1.24	0.00
Osteoblast, donor1	11277-116H8	14.07	4.50	1.17	0.20	0.00
Osteoblast, donor2	11354-117H4	66.72	18.96	4.21	0.70	0.00
Osteoblast, donor3	11426-118G4	44.61	8.89	3.02	0.71	0.18
Pancreatic stromal cells, donor1	11249-116E7	71.94	11.79	4.21	0.93	0.51
Pericytes, donor1	11491-119E6	11.46	7.90	0.56	0.45	0.00
Pericytes, donor2	11571-120E5	16.30	9.51	0.68	0.91	0.00
Pericytes, donor3	11652-122E5	28.89	9.36	3.05	1.22	0.00
Perineurial Cells, donor1	11499-119F5	64.87	16.28	3.50	1.24	0.11
Perineurial Cells, donor2	11579-120F4	68.64	9.39	3.22	0.74	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	96.26	33.15	4.14	0.96	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	60.24	21.06	1.71	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	75.71	23.42	2.59	0.91	0.52
Placental Epithelial Cells, donor1	11278-116H9	16.26	7.65	1.43	0.96	0.24
Placental Epithelial Cells, donor2	11355-117H5	26.61	9.98	1.11	3.33	0.00
Placental Epithelial Cells, donor3	11427-118G5	19.24	4.91	0.79	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	80.70	8.23	7.59	2.53	0.00
Preadipocyte - breast, donor1	11467-119B9	65.66	9.38	6.19	1.13	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	26.63	5.09	2.74	0.78	1.57
Preadipocyte - breast, donor2	11328-117E5	67.09	9.01	4.73	1.80	1.35
Preadipocyte - omental, donor1	11468-119C1	63.72	8.84	5.86	1.60	1.39
Preadipocyte - omental, donor2	11329-117E6	76.82	13.97	7.86	1.31	0.44
Preadipocyte - omental, donor3	11403-118D8	82.22	13.04	5.30	1.72	1.00
Preadipocyte - perirenal, donor1	11469-119C2	25.59	3.94	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	15.66	4.30	1.54	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	79.15	23.73	7.97	2.12	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	53.64	12.77	4.77	1.70	0.17
Preadipocyte - visceral, donor1	11280-116I2	86.35	17.88	6.80	2.42	1.12
Preadipocyte - visceral, donor2	11357-117H7	58.90	14.27	5.06	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	69.38	17.87	7.21	1.25	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	51.74	20.06	2.87	0.91	0.45
Prostate Epithelial Cells, donor2	11331-117E8	37.37	10.02	2.44	0.68	0.00
Prostate Epithelial Cells, donor3	11404-118D9	40.54	12.19	1.78	1.29	0.06
Prostate Stromal Cells, donor1	11254-116F3	45.90	13.10	3.42	1.03	0.57
Prostate Stromal Cells, donor2	11332-117E9	50.74	17.03	3.41	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	53.39	9.18	2.92	1.56	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.77	9.49	1.46	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.57	14.42	1.80	0.42	0.14
Renal Epithelial Cells, donor1	11517-119H5	10.14	11.16	1.01	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.96	5.69	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	48.59	16.73	2.54	0.53	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.94	13.62	0.68	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	30.86	15.50	3.50	1.35	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	34.19	15.76	3.55	0.89	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	2.66	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	13.43	11.00	2.20	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	21.94	10.66	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	7.21	4.72	0.55	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	27.65	21.21	4.29	1.88	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	16.02	13.92	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	20.06	9.84	1.35	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	44.34	14.78	1.30	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	27.00	9.10	2.27	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	8.23	3.09	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	52.19	13.55	1.51	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	88.60	8.29	4.01	1.07	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	81.30	6.25	2.68	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	130.99	4.40	1.65	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	158.35	9.28	4.06	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	112.08	14.30	8.58	0.13	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	81.63	9.63	3.97	0.70	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	102.39	11.04	7.14	1.67	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	134.71	13.02	6.08	1.24	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	101.16	8.51	5.59	0.82	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	96.15	7.63	5.32	1.39	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	73.93	10.13	4.11	0.82	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	89.25	9.38	5.29	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	88.34	10.75	5.73	0.72	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	78.47	8.61	4.02	0.57	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	78.12	9.12	4.61	0.75	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	99.35	8.63	4.20	1.11	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	79.15	10.13	2.87	0.57	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	78.35	9.22	4.66	0.75	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	118.38	9.58	6.76	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	94.49	9.69	7.70	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	83.13	8.37	3.80	0.78	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	102.16	8.78	4.39	0.57	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	90.24	9.50	3.74	1.17	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	81.01	8.69	5.89	1.40	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	91.43	11.62	5.13	0.85	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	87.70	7.66	5.65	0.36	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	77.87	9.44	6.13	0.61	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	92.95	9.67	4.16	1.88	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	79.49	9.67	4.95	0.24	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	78.77	10.71	5.56	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	100.32	10.99	6.55	1.40	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	81.91	11.61	4.35	2.07	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	85.39	8.63	4.20	0.22	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	94.00	10.03	6.89	1.04	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	93.94	9.42	6.19	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	83.27	9.71	5.28	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	103.72	13.50	5.98	0.19	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	90.78	10.83	4.47	0.17	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	83.81	11.93	5.90	1.37	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	101.13	9.69	4.60	0.82	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	79.59	6.65	4.26	0.68	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	85.22	9.77	4.44	0.30	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	90.36	8.80	4.80	1.33	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	87.80	6.36	4.15	0.41	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	84.05	5.00	1.67	0.95	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	122.74	9.07	5.44	2.62	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	75.81	4.71	3.39	0.75	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	102.71	6.64	4.54	1.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	84.32	6.04	2.72	1.21	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	81.63	4.04	3.30	0.49	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	200.13	11.50	5.39	1.31	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	88.22	5.48	3.65	2.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	80.47	4.52	3.32	0.60	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	76.90	5.43	4.52	0.90	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	83.57	10.78	3.29	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	90.56	7.56	3.78	0.83	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	75.77	6.19	3.84	0.85	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	115.99	7.81	4.81	1.20	0.60
Schwann Cells, donor1	11498-119F4	14.67	11.66	0.56	0.19	0.19
Schwann Cells, donor2	11578-120F3	27.22	20.41	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	31.33	12.05	1.31	1.53	0.22
Sebocyte, donor1	11220-116B5	32.32	10.96	3.29	0.55	0.55
Sebocyte, donor2	11301-117B5	35.85	8.73	4.14	0.46	0.00
Sebocyte, donor3	11378-118B1	27.21	11.95	1.86	0.82	0.21
Sertoli Cells, donor1	11255-116F4	82.83	8.28	3.31	1.66	0.00
Sertoli Cells, donor2	11333-117F1	59.31	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	41.88	10.56	2.73	0.53	0.00
Skeletal Muscle Cells, donor2	11358-117H8	16.63	1.45	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	22.57	6.69	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	73.21	19.48	4.40	1.10	0.31
Skeletal Muscle Cells, donor5	11455-119A6	69.71	13.97	4.76	1.04	0.59
Skeletal Muscle Cells, donor6	11459-119B1	80.34	22.01	7.54	1.69	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	111.77	17.39	4.16	1.39	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	84.19	12.70	4.14	0.57	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	84.92	18.75	4.76	1.49	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	44.91	9.27	2.95	1.52	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	5.07	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	17.61	4.27	1.51	0.14	0.00
Skin - palm, donor1	10286-104F7	64.47	5.37	5.37	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	31.43	7.06	3.32	1.01	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	25.35	11.45	1.64	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	33.24	9.22	4.15	0.91	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	67.70	14.18	4.87	0.97	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	42.06	8.30	3.24	0.84	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	31.51	11.00	2.33	0.42	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	45.94	11.99	4.35	1.50	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	42.28	14.19	2.16	1.85	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	11.34	3.11	1.33	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	49.38	10.58	1.76	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.47	7.29	2.43	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.39	5.51	1.58	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	33.22	10.82	2.32	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	54.04	7.01	5.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	25.68	7.85	2.79	0.13	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	46.55	15.07	2.44	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	45.07	14.08	6.27	2.56	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	54.05	19.54	4.88	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	70.58	18.90	2.95	1.48	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	55.52	12.10	3.70	2.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.68	15.13	2.93	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	43.84	7.31	1.83	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	22.73	3.54	2.53	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	14.78	4.29	1.91	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	51.32	11.36	1.77	0.88	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	50.15	10.33	1.72	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	58.15	9.66	3.46	1.15	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	22.12	7.12	2.01	0.62	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	4.31	2.16	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	18.83	8.37	0.90	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.56	5.12	1.02	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	78.14	6.60	2.51	0.86	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	57.06	12.78	4.23	1.51	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	49.61	9.10	3.64	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.13	5.43	1.81	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	86.37	37.09	5.83	4.50	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	73.90	16.78	7.32	2.00	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	54.47	11.77	4.13	1.50	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.42	12.94	2.79	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	47.49	11.61	2.86	0.75	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	4.50	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	21.97	5.17	25.84	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.93	5.12	2.79	1.86	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	33.83	5.05	2.02	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.00	7.52	3.45	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	21.24	6.19	2.06	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	81.81	24.33	5.58	1.58	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	60.73	6.54	3.74	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	22.31	7.48	2.59	1.30	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	26.26	7.39	2.80	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	21.62	4.14	2.63	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	70.29	21.52	4.05	1.54	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	59.74	15.58	2.43	1.84	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	0.95	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	22.75	8.07	2.45	0.73	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	81.97	20.99	5.52	1.77	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	45.06	14.63	2.63	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	56.36	3.69	3.69	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	38.61	14.02	3.70	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	75.13	5.95	2.60	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	58.57	16.89	5.03	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	41.17	8.80	3.41	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	70.90	17.72	6.70	0.79	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	60.69	5.84	2.79	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	73.87	3.99	2.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	50.16	3.34	1.25	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	55.46	5.50	2.75	0.00	0.46
Synoviocyte, donor1	11291-117A4	60.09	8.75	5.05	1.18	0.67
Synoviocyte, donor2	11368-117I9	81.13	4.86	4.19	1.17	0.34
Synoviocyte, donor3	11440-118H9	88.02	6.26	3.13	1.12	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	23.94	13.58	1.79	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	12.04	4.86	0.93	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	42.37	19.64	2.51	1.22	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	11.98	6.19	1.55	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	13.74	4.01	2.29	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	94.48	10.83	4.06	1.85	0.25
Urethra, donor2	10319-105A4	66.54	19.78	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	13.55	10.89	2.39	0.53	0.00
Urothelial Cells, donor2	11600-120H7	12.82	3.61	1.60	0.40	0.00
Urothelial Cells, donor3	11681-122H7	13.75	3.90	0.69	0.00	0.00
Urothelial cells, donor0	11216-116B1	67.54	15.83	2.67	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	58.73	21.35	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	68.62	25.73	1.43	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	41.07	6.16	0.68	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	42.01	13.77	0.69	1.38	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	47.64	12.20	1.16	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	42.69	15.62	1.04	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	56.90	17.44	1.84	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	26.47	11.87	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	72.17	18.01	6.54	2.47	0.62
Wilms' tumor cell line:HFWT	10597-108E3	37.84	12.32	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	35.75	10.61	2.51	0.28	0.00
achilles tendon, donor2	10292-104G4	33.06	10.33	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	129.52	19.89	7.90	3.06	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	73.60	22.06	7.20	1.86	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	112.06	19.23	4.27	1.78	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	115.65	47.62	8.71	2.18	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	88.82	21.36	6.75	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	56.89	17.76	3.60	0.63	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	83.57	5.99	4.63	0.54	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	60.81	8.81	2.20	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	89.43	10.62	2.04	1.23	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	72.61	15.53	3.11	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	123.46	19.32	9.94	0.92	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	97.51	11.70	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	31.37	8.13	3.49	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	169.58	21.23	6.47	0.78	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	66.92	17.83	3.51	0.88	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	33.93	33.46	2.79	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	40.71	9.46	1.65	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	60.78	36.22	5.22	4.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	62.73	48.22	6.40	3.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	59.45	43.98	4.55	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	76.54	44.53	4.33	2.41	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	49.00	10.25	3.34	1.11	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	42.69	31.69	3.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	117.07	55.75	7.43	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	40.68	54.99	4.90	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	88.53	17.88	3.93	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	61.86	48.74	5.62	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	71.36	4.95	2.59	0.71	1.18
adipose tissue, adult, pool1	10010-101C1	76.94	9.77	3.72	1.24	0.00
adipose, donor1	10184-103D4	119.04	19.94	2.35	0.59	0.00
adipose, donor2	10185-103D5	42.17	14.60	0.81	0.41	0.00
adipose, donor3	10186-103D6	42.75	17.70	3.00	1.09	0.54
adipose, donor4	10187-103D7	51.14	24.27	1.73	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	60.76	29.51	5.52	1.42	0.32
adrenal gland, adult, pool1	10081-102A9	47.29	10.91	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	53.50	7.34	1.20	0.40	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	103.26	13.93	7.15	1.43	0.36
amniotic membrane cells, donor1	12235-129G3	80.22	11.13	2.78	0.93	1.62
amniotic membrane cells, donor2	12236-129G4	63.56	19.61	2.37	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	89.56	14.73	2.36	1.77	2.06
amygdala - adult, donor10196	10167-103B5	62.85	18.97	3.56	0.00	0.00
amygdala, adult, donor10252	10151-102I7	65.90	18.05	5.47	1.01	0.61
amygdala, newborn, donor10223	10360-105E9	53.58	10.01	1.94	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	37.43	12.10	2.29	1.53	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	95.09	29.12	7.50	3.53	1.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	101.88	9.69	5.68	0.67	2.00
aorta, adult, pool1	10052-101G7	64.33	8.24	3.14	0.20	0.00
appendix, adult	10189-103D9	66.76	13.97	5.82	1.16	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	115.91	11.69	4.13	2.06	2.41
artery, adult	10190-103E1	139.94	1.36	6.79	5.43	1.36
astrocytoma cell line:TM-31	10425-106D2	83.88	28.39	3.33	1.16	0.58
b cell line:RPMI1788	10427-106D4	70.19	18.59	2.53	1.64	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	88.51	13.87	3.61	0.83	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	28.08	16.37	1.98	0.89	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	30.30	21.09	3.68	1.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	35.23	5.03	1.68	0.56	0.00
bladder, adult, pool1	10011-101C2	112.44	13.69	5.43	1.09	0.22
blood, adult, pool1	10053-101G8	39.86	11.07	4.43	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	88.20	27.40	8.56	0.86	3.43
bone marrow, adult	10192-103E3	77.60	10.12	4.05	1.35	1.35
brain, adult, donor1	10084-102B3	35.88	6.15	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	54.01	13.70	3.23	0.78	0.22
brain, fetal, pool1	10085-102B4	10.69	5.34	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	64.42	20.48	4.29	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	81.51	19.97	5.99	1.50	0.62
breast, adult, donor1	10080-102A8	78.29	13.26	6.94	3.79	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	43.70	29.09	3.81	2.29	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.88	11.13	0.62	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	51.11	45.58	5.30	1.15	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	36.56	9.20	2.91	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	119.89	13.16	4.23	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	66.50	23.08	4.81	1.20	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	96.65	16.16	2.54	1.27	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	85.98	15.17	2.40	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	66.78	24.18	5.76	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	58.23	12.55	2.18	1.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	77.18	19.87	2.29	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	60.79	11.72	4.03	0.00	2.56
cerebellum - adult, donor10196	10173-103C2	145.66	20.39	8.74	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	112.09	10.68	3.63	0.21	0.43
cerebellum, adult, pool1	10083-102B2	60.37	13.45	3.10	1.72	0.00
cerebellum, newborn, donor10223	10357-105E6	113.75	14.11	6.64	0.83	0.83
cerebral meninges, adult	10188-103D8	66.82	13.87	2.52	1.26	0.25
cerebrospinal fluid, donor2	10294-104G6	52.62	9.50	3.65	5.12	0.00
cervical cancer cell line:D98-AH2	10552-107I3	103.38	30.34	6.61	1.58	0.58
cervical cancer cell line:ME-180	10553-107I4	43.42	12.26	3.65	0.50	1.82
cervix, adult, pool1	10013-101C4	88.72	16.69	3.57	0.73	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	57.96	21.04	6.55	1.81	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	35.27	11.76	7.84	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	67.73	18.02	6.59	1.86	0.37
choriocarcinoma cell line:SCH	10785-110H2	17.87	33.27	1.72	1.11	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	44.59	27.04	4.27	1.90	0.24
chorionic membrane cells, donor1	12238-129G6	41.88	3.99	1.99	1.42	0.57
chorionic membrane cells, donor2	12239-129G7	61.45	18.49	4.67	0.70	0.40
chorionic membrane cells, donor3	12240-129G8	53.85	7.14	1.10	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	65.64	21.21	3.03	1.01	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	55.32	13.06	2.31	0.38	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	54.91	15.21	2.32	1.06	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	43.91	20.03	1.54	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	52.00	16.45	3.63	1.45	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.96	15.27	3.87	1.02	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	130.15	44.17	7.07	4.12	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	100.08	33.88	4.17	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	40.69	20.57	1.60	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	23.08	11.97	1.74	0.87	0.17
colon carcinoma cell line:CACO-2	10513-107D9	75.23	20.13	8.05	2.20	1.46
colon carcinoma cell line:COLO-320	10420-106C6	115.16	11.40	1.90	0.38	0.00
colon, adult, donor1	10082-102B1	30.94	5.95	5.95	1.19	0.00
colon, adult, pool1	10014-101C5	101.52	18.68	4.35	1.76	2.47
colon, fetal, donor1	10070-101I7	67.36	8.65	4.33	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	41.25	22.92	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	65.86	15.30	3.82	2.97	4.25
cord blood derived cell line:COBL-a 24h infection	10453-106G3	51.77	10.26	4.83	0.75	1.21
cord blood derived cell line:COBL-a untreated	10449-106F8	70.79	12.13	4.09	2.12	1.41
corpus callosum, adult, pool1	10042-101F6	47.32	22.22	4.20	1.11	0.11
cruciate ligament, donor2	10295-104G7	59.97	6.48	3.24	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	129.21	8.83	8.83	3.21	0.00
diencephalon, adult	10193-103E4	49.20	20.88	5.76	1.68	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	57.40	7.12	4.13	1.15	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	60.01	17.44	5.13	1.03	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	70.77	14.44	5.06	1.44	0.48
ductus deferens, adult	10196-103E7	69.27	10.96	4.98	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	69.13	14.40	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	69.89	12.51	3.68	0.00	0.74
dura mater, adult, donor1	10041-101F5	63.59	24.28	5.86	1.07	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	86.61	15.32	7.11	4.44	17.10
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	86.84	39.12	8.45	5.45	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	53.03	36.38	4.93	3.08	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	27.24	20.89	3.03	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	53.72	29.33	4.94	1.23	0.00
embryonic pancreas cell line:2C6	10603-108E9	38.09	35.46	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	40.56	11.73	2.68	1.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	80.29	26.10	4.53	1.45	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	29.11	11.26	2.89	0.48	0.16
epidermoid carcinoma cell line:A431	10426-106D3	56.80	12.12	2.67	0.67	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	31.90	10.23	2.97	0.44	0.44
epididymis, adult	10197-103E8	68.65	12.77	4.19	1.88	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.72	17.74	1.95	0.89	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	50.73	12.58	4.33	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	57.66	9.57	4.72	1.83	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	72.54	8.07	4.33	2.17	1.38
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	61.62	11.54	3.92	2.91	0.78
esophagus, adult, pool1	10015-101C6	94.18	9.77	4.78	1.27	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	57.48	39.32	4.01	1.38	0.13
eye - muscle inferior rectus, donor1	10272-104E2	43.46	14.49	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	73.65	14.73	8.42	0.00	4.21
eye - muscle medial, donor2	10299-104H2	49.11	11.91	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	50.45	13.76	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	20.40	5.83	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	86.44	15.25	2.03	1.53	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	56.80	15.64	3.46	0.64	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	50.57	44.87	6.65	1.66	0.71
frontal lobe, adult, pool1	10040-101F4	73.56	17.73	3.19	0.94	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	53.14	30.02	1.80	1.20	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	37.95	13.26	1.46	0.46	0.46
gall bladder, adult	10198-103E9	68.33	14.24	2.90	0.97	0.24
gamma delta positive T cells, donor1	11937-126A2	90.19	31.67	4.29	2.15	0.54
gamma delta positive T cells, donor2	11938-126A3	88.89	25.02	2.24	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	45.20	12.88	2.75	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.40	11.99	2.13	0.97	0.19
gastric cancer cell line:AZ521	10549-107H9	70.99	25.74	4.59	1.97	0.49
gastric cancer cell line:GSS	10560-108A2	120.81	28.37	1.83	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	56.43	14.39	4.11	0.23	1.14
giant cell carcinoma cell line:LU65	10487-107B1	62.65	22.14	3.67	1.84	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	24.77	27.71	1.68	0.56	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	38.66	19.21	6.73	1.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	50.14	14.04	4.64	0.84	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	50.14	19.38	4.49	0.84	0.28
glioblastoma cell line:T98G	10485-107A8	45.14	11.92	2.32	0.77	0.22
glioma cell line:GI-1	10413-106B8	40.12	4.69	1.46	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	62.69	36.45	7.29	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	99.35	30.27	3.66	1.71	0.00
globus pallidus, adult, donor10258	10367-105F7	58.88	20.54	2.74	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	42.63	13.86	2.13	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	34.26	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	41.28	6.72	5.12	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	67.95	27.55	6.43	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	55.79	23.78	7.32	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	59.90	25.76	6.44	0.00	0.00
hIPS, biol_rep1	14380-156B6	48.87	28.75	8.62	0.00	1.44
hIPS, biol_rep2	14381-156B7	43.90	26.75	7.54	0.69	0.69
hIPS, biol_rep3	14382-156B8	51.86	20.97	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	38.50	12.07	1.44	1.72	0.29
heart - mitral valve, adult	10205-103F7	78.33	9.27	4.19	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	95.18	17.26	6.28	1.05	1.05
heart - tricuspid valve, adult	10207-103F9	94.92	14.99	10.82	5.83	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	34.08	12.45	3.26	1.22	0.20
heart, adult, diseased, donor1	10051-101G6	28.53	6.39	1.70	0.85	0.43
heart, adult, pool1	10016-101C7	144.89	31.05	13.34	4.60	0.92
heart, fetal, pool1	10046-101G1	112.74	14.48	5.03	1.54	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	85.46	11.42	4.94	1.23	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	57.08	5.95	4.76	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	86.52	15.36	4.86	1.44	3.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	99.28	13.72	2.91	1.70	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	95.70	16.07	3.23	1.41	3.13
hepatoma cell line:Li-7	10484-107A7	71.29	31.70	6.34	2.56	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	80.10	25.13	5.23	2.61	0.40
hippocampus - adult, donor10196	10169-103B7	61.51	21.77	3.79	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	72.66	20.41	4.29	1.63	0.41
hippocampus, adult, donor10258	10374-105G5	37.35	18.42	5.48	0.50	1.00
hippocampus, newborn, donor10223	10363-105F3	43.00	9.87	3.88	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	74.46	29.30	5.49	5.49	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	38.49	25.13	4.52	2.75	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.89	28.44	5.59	1.02	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	45.67	13.53	1.69	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	43.64	14.20	2.07	0.26	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	39.48	18.22	2.28	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	45.54	18.10	2.04	0.58	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	38.78	15.94	1.29	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	45.46	19.60	3.34	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	43.33	23.21	5.92	1.42	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	49.18	20.41	2.73	1.77	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	53.86	22.89	5.39	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.18	19.72	3.76	2.35	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	32.92	14.74	6.39	1.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	65.46	22.69	4.36	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	48.49	13.17	3.25	0.95	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	38.81	14.83	1.31	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	61.47	14.99	1.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	30.90	16.58	1.70	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	31.83	16.82	2.73	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	49.18	15.98	3.13	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	51.11	15.68	4.08	1.14	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	54.58	17.71	2.61	1.74	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	53.81	14.05	4.18	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	38.43	21.43	4.25	0.92	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	35.66	26.53	5.71	1.14	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	58.39	26.95	8.17	1.22	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	50.00	21.48	2.82	1.06	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	42.44	16.79	2.53	1.58	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.95	12.41	2.12	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	38.27	20.68	2.07	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	41.18	21.25	2.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	42.33	17.70	2.31	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	54.96	20.96	2.81	1.53	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	54.52	20.45	4.54	0.76	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	61.83	20.16	5.38	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	39.37	18.84	5.31	2.17	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	45.46	23.62	10.70	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	54.15	15.61	5.85	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	43.09	18.64	2.75	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	224.47	52.05	9.76	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	59.90	17.87	2.98	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	44.88	20.25	3.83	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.25	13.75	3.26	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	33.45	13.17	1.78	1.42	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	31.03	13.13	3.58	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	54.44	26.27	5.69	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	44.18	19.13	2.69	1.08	0.00
immature langerhans cells, donor1	11904-125F5	84.02	23.97	8.72	1.45	3.63
immature langerhans cells, donor2	11905-125F6	35.65	4.75	4.75	0.79	0.00
insula, adult, pool1	10039-101F3	49.68	14.67	2.27	1.42	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	34.47	5.53	1.95	0.00	0.65
kidney, adult, pool1	10017-101C8	78.70	20.03	6.51	2.30	0.90
kidney, fetal, pool1	10045-101F9	23.56	9.76	1.70	0.50	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	65.05	18.60	4.69	0.85	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	28.06	3.73	1.80	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	37.80	28.81	2.57	1.47	0.00
left atrium, adult, donor1	10079-102A7	77.37	11.44	4.90	2.18	0.54
left ventricle, adult, donor1	10078-102A6	81.41	17.70	5.06	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	84.55	18.33	4.38	2.19	0.00
leiomyoma cell line:10964C	10569-108B2	31.61	8.26	3.95	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	30.98	10.87	3.80	1.09	0.54
leiomyoma cell line:15425	10571-108B4	41.76	10.44	1.94	1.21	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	0.00	6.35	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	75.28	16.73	5.23	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	71.31	12.28	3.78	1.89	0.94
liposarcoma cell line:KMLS-1	10782-110G8	61.86	13.28	4.22	1.56	0.47
liposarcoma cell line:SW 872	10726-110A6	46.30	7.68	3.29	0.37	0.49
liver, adult, pool1	10018-101C9	75.20	7.94	5.67	1.30	0.81
liver, fetal, pool1	10086-102B5	14.11	6.58	0.94	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	67.37	23.92	4.67	2.04	0.29
locus coeruleus, adult, donor10252	10165-103B3	64.59	20.67	4.06	1.85	0.37
locus coeruleus, adult, donor10258	10375-105G6	47.68	15.52	3.67	1.13	0.00
locus coeruleus, newborn, donor10223	10362-105F2	72.35	18.93	2.52	2.10	0.84
lung adenocarcinoma cell line:A549	10499-107C4	36.40	10.38	2.08	1.25	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	58.60	14.48	2.07	2.76	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	49.83	18.45	2.24	0.92	0.13
lung, adult, pool1	10019-101D1	79.62	18.19	3.54	0.83	0.00
lung, fetal, donor1	10068-101I5	133.29	23.97	4.57	1.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	56.82	10.54	3.67	0.46	0.00
lymph node, adult, donor1	10077-102A5	42.60	23.67	4.73	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	48.66	11.40	1.32	1.32	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	136.59	10.11	7.40	3.47	5.58
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	51.82	26.33	6.80	1.70	2.55
mature adipocyte, donor1	12231-129F8	110.55	5.33	7.10	1.33	1.33
mature adipocyte, donor2	12232-129F9	119.12	8.92	8.09	1.04	0.62
mature adipocyte, donor3	12233-129G1	127.78	6.40	5.69	2.61	0.47
mature adipocyte, donor4	12234-129G2	144.77	5.79	7.63	1.05	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	81.01	24.54	7.86	2.62	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	55.27	15.79	6.77	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	62.90	14.71	4.41	1.47	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	50.19	12.39	2.54	0.95	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	78.47	14.07	3.84	0.85	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	84.38	16.54	5.74	1.01	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	72.79	13.37	4.67	0.64	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	19.26	7.71	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	244.01	28.71	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	51.33	10.05	3.95	0.00	1.44
medulla oblongata - adult, donor10196	10174-103C3	56.46	18.17	6.49	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	74.62	14.09	4.80	1.24	0.31
medulla oblongata, adult, pool1	10038-101F2	40.98	21.55	3.75	0.90	0.24
medulla oblongata, newborn, donor10223	10361-105F1	48.26	13.89	3.82	1.04	0.35
medulloblastoma cell line:D283 Med	10838-111E1	43.18	25.91	4.43	1.33	0.00
medulloblastoma cell line:ONS-76	10759-110E3	40.35	14.92	2.57	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	85.24	8.62	3.88	2.30	1.29
melanoma cell line:G-361	10465-106H6	32.30	11.94	1.09	0.81	0.54
meningioma cell line:HKBMM	10691-109F7	50.47	8.14	1.63	1.27	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	122.48	14.98	5.29	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	57.03	18.15	2.07	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	96.36	15.04	6.60	1.84	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	74.17	15.63	2.91	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	60.04	6.63	2.48	2.48	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	98.75	4.50	3.65	0.84	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	90.12	6.74	2.31	0.96	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	50.67	11.80	2.78	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	55.61	9.95	2.57	0.86	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	62.11	8.74	2.65	0.58	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	70.96	7.69	5.17	0.66	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	55.50	11.07	2.57	1.22	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	76.82	10.81	3.98	1.28	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	29.64	9.55	3.29	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	65.45	11.62	4.70	1.25	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	65.28	12.22	2.79	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	68.60	14.90	5.92	0.41	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	25.88	11.86	1.80	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	60.41	8.90	2.28	0.83	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	23.26	6.84	2.96	1.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	70.07	28.11	9.23	1.26	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	63.96	7.02	3.89	0.60	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	70.64	7.44	3.50	0.79	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	68.11	5.89	1.47	1.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	30.05	12.30	3.72	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	79.15	13.89	3.79	2.11	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	59.37	10.50	1.83	1.83	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	55.51	9.98	5.12	1.53	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	60.47	10.99	4.71	2.09	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	57.92	13.86	4.31	1.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	65.90	16.00	2.82	1.18	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	55.85	9.48	3.38	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	56.98	11.00	3.14	2.36	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	50.51	10.19	2.32	3.71	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	71.24	11.25	5.48	2.60	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	61.35	12.05	5.35	2.01	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	56.48	10.82	3.36	2.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	83.60	8.07	8.07	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	57.06	6.04	4.36	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	53.22	11.87	2.87	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	70.02	11.60	4.30	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	10.94	8.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	72.31	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	73.08	13.32	5.52	0.97	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	69.84	2.91	5.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	84.76	14.93	8.53	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	64.60	12.27	6.54	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	68.03	9.72	4.28	1.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	65.06	16.79	8.39	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	50.67	8.94	7.95	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	69.97	11.86	3.56	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	74.33	4.87	8.53	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	84.24	8.87	3.80	2.53	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	82.78	6.21	3.79	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	96.71	8.60	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	79.21	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	79.86	1.22	2.04	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	91.36	1.59	3.18	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	76.64	0.00	3.54	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	91.33	3.43	2.49	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	73.52	4.01	2.67	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	76.87	4.73	3.55	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	77.04	7.70	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	91.56	2.07	8.26	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	95.99	4.45	5.94	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	72.90	6.73	5.61	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	92.23	7.63	8.90	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	82.61	2.42	7.25	1.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	76.32	6.54	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	57.02	8.87	2.53	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	86.78	10.32	4.86	2.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	90.38	9.04	13.56	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	91.43	5.77	5.77	4.94	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	94.45	8.53	6.55	2.58	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	70.74	9.41	5.52	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	84.55	4.07	3.06	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	71.96	25.53	3.09	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	77.01	52.68	7.09	1.18	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	43.32	12.51	3.71	1.16	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	59.83	17.09	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	124.33	20.76	7.81	1.23	0.21
mesothelioma cell line:Mero-25	10850-111F4	39.26	37.45	4.09	1.59	0.91
mesothelioma cell line:Mero-41	10851-111F5	44.01	12.22	4.16	0.98	0.24
mesothelioma cell line:Mero-48a	10852-111F6	75.07	17.94	6.64	1.11	0.66
mesothelioma cell line:Mero-82	10853-111F7	58.87	11.56	3.94	1.84	1.05
mesothelioma cell line:Mero-83	10854-111F8	24.68	4.60	1.87	0.68	0.00
mesothelioma cell line:Mero-84	10855-111F9	39.18	11.12	3.54	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	33.75	10.35	2.90	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	33.63	18.72	4.31	0.33	0.33
mesothelioma cell line:NCI-H226	10846-111E9	61.54	13.94	5.07	1.09	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	76.02	18.96	4.78	1.02	0.17
mesothelioma cell line:NCI-H28	10845-111E8	38.17	15.78	1.78	0.51	0.00
mesothelioma cell line:No36	10857-111G2	21.53	6.20	1.96	2.28	0.33
mesothelioma cell line:ONE58	10858-111G3	67.74	20.32	6.23	1.35	0.27
migratory langerhans cells, donor1	11901-125F2	25.53	8.06	2.69	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	23.20	8.30	1.95	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	64.43	12.74	1.08	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	94.35	39.50	5.22	0.98	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	43.66	16.11	1.91	2.33	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	40.77	20.50	5.53	2.30	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	63.18	12.94	5.14	1.14	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	71.33	20.70	2.96	0.74	0.00
myeloma cell line:PCM6	10474-106I6	79.07	10.67	4.35	0.99	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	52.25	13.19	3.55	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	65.90	7.06	1.18	0.98	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	48.02	19.72	1.78	1.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	47.07	18.75	2.94	0.37	0.00
nasal epithelial cells, donor2	12227-129F4	37.54	14.90	2.76	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	113.19	25.08	8.74	2.30	1.15
neuroblastoma cell line:NB-1	10539-107G8	111.32	21.51	7.48	1.31	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	86.68	12.44	6.96	2.11	0.21
neuroblastoma cell line:NH-12	10555-107I6	105.66	17.70	4.29	2.24	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	75.44	6.64	4.98	1.66	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	59.08	18.85	2.85	1.11	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	107.67	20.13	3.82	1.21	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	85.19	50.23	7.63	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	73.20	7.98	5.06	1.06	0.00
neutrophil PMN, donor1	12133-128D9	29.75	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	46.68	32.98	2.20	0.51	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	56.04	14.41	4.80	1.60	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	53.22	16.03	4.49	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	43.88	13.40	2.36	1.84	0.26
nucleus accumbens, adult, pool1	10037-101F1	53.43	17.06	2.34	1.12	0.00
occipital cortex - adult, donor10196	10172-103C1	125.68	14.42	6.18	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	78.36	15.03	3.49	1.88	0.27
occipital cortex, newborn, donor10223	10355-105E4	56.05	10.19	4.00	0.00	1.09
occipital lobe, adult, donor1	10076-102A4	70.32	11.55	4.20	0.79	0.26
occipital lobe, fetal, donor1	10073-102A1	51.49	12.87	2.15	0.00	0.43
occipital pole, adult, pool1	10036-101E9	29.33	6.94	1.81	0.32	0.00
olfactory region, adult	10195-103E6	36.68	9.36	2.29	0.19	0.00
optic nerve, donor1	10277-104E7	58.03	36.02	8.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	52.85	7.29	3.08	0.57	1.94
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	63.47	15.80	2.47	0.55	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	45.89	13.72	3.39	1.35	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	46.20	7.97	2.77	0.69	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	50.86	11.46	2.65	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	213.96	45.78	12.15	4.67	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	62.77	15.06	2.76	1.48	1.27
ovary, adult, pool1	10020-101D2	90.85	14.06	4.11	2.01	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	33.91	8.07	3.48	0.55	0.00
pancreas, adult, donor1	10049-101G4	117.58	7.53	12.23	1.88	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	44.17	10.06	5.03	3.07	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	49.91	21.46	5.11	0.68	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	38.75	12.42	2.32	0.00	0.83
paracentral gyrus, adult, pool1	10035-101E8	54.00	14.00	2.29	1.28	0.09
parietal cortex, adult, donor10258	10373-105G4	42.57	13.95	3.67	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	56.43	13.17	4.70	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	61.00	12.54	4.56	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	46.44	11.46	3.17	1.06	0.26
parietal lobe, fetal, donor1	10072-101I9	53.34	17.46	6.79	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	53.84	8.97	2.99	0.75	0.37
parotid gland, adult	10199-103F1	129.50	4.32	7.40	1.23	1.23
penis, adult	10200-103F2	76.81	7.52	4.83	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	124.39	34.77	10.78	1.86	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	34.09	22.87	2.33	1.02	0.29
pineal gland - adult, donor10196	10179-103C8	65.15	15.48	3.87	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	127.33	16.58	3.55	2.96	0.00
pineal gland, adult, donor10258	10377-105G8	80.89	8.15	2.51	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	107.25	22.26	7.08	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	193.88	21.89	4.17	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	131.94	16.17	3.40	0.00	0.00
placenta, adult, pool1	10021-101D3	49.45	9.57	3.98	1.08	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	54.03	17.22	2.78	1.59	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	99.76	18.99	6.38	0.78	0.16
pons, adult, pool1	10033-101E6	81.76	21.09	5.77	1.72	0.86
postcentral gyrus, adult, pool1	10032-101E5	37.05	10.03	2.88	0.61	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	4.18	8.37	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	27.97	16.61	3.20	0.58	0.29
prostate cancer cell line:PC-3	10439-106E7	80.04	19.60	4.54	1.45	0.00
prostate, adult, pool1	10022-101D4	96.77	14.51	4.26	2.09	0.45
putamen, adult, donor10196	10176-103C5	67.99	11.80	4.01	1.18	0.24
putamen, adult, donor10252	10152-102I8	52.94	17.65	7.84	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	52.45	15.30	2.19	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	60.40	18.36	3.62	0.72	0.24
putamen, newborn, donor10223	10365-105F5	78.71	15.74	5.25	1.50	2.25
rectal cancer cell line:TT1TKB	10469-106I1	51.50	12.51	3.78	0.29	0.00
rectum, fetal, donor1	10067-101I4	83.46	19.47	2.78	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.18	8.27	1.48	0.21	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	70.00	7.87	3.31	2.49	0.00
retina, adult, pool1	10030-101E3	49.30	13.82	3.18	0.10	0.40
retinoblastoma cell line:Y79	10475-106I7	69.63	8.05	1.82	0.26	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	69.22	13.65	4.30	1.60	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	175.75	23.34	4.50	1.12	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	91.70	8.34	5.30	1.52	0.00
salivary acinar cells, donor1	11771-123I7	80.44	10.20	4.37	1.62	0.00
salivary acinar cells, donor2	11772-123I8	67.05	6.47	3.72	0.55	0.14
salivary acinar cells, donor3	11773-123I9	86.73	5.96	5.30	1.32	0.00
salivary gland, adult, pool1	10093-102C3	93.80	12.01	5.72	1.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	61.55	13.74	3.79	0.42	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	66.89	13.99	2.70	0.82	0.47
seminal vesicle, adult	10201-103F3	88.88	13.23	2.65	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.82	14.33	2.19	0.97	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	57.12	11.83	2.77	1.26	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	47.17	20.07	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.71	5.51	1.88	0.94	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	61.12	21.33	2.65	1.22	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	43.61	7.74	2.45	0.77	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	115.62	19.15	9.22	2.13	2.13
skeletal muscle, adult, pool1	10023-101D5	173.19	13.55	9.71	5.76	0.84
skeletal muscle, fetal, donor1	10066-101I3	36.18	6.03	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	94.99	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	74.48	7.57	2.52	2.52	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	43.02	27.68	4.00	3.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	78.17	11.03	5.04	0.95	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	67.85	41.63	3.28	0.58	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	67.91	18.46	3.79	1.98	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	87.82	15.92	2.73	1.77	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	64.07	8.93	3.27	0.87	1.96
small intestine, adult, pool1	10024-101D6	93.05	15.41	4.90	2.03	2.99
small intestine, fetal, donor1	10064-101I1	60.93	10.56	2.70	1.72	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	49.24	4.62	1.54	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	101.06	9.56	3.10	2.33	0.52
somatostatinoma cell line:QGP-1	10781-110G7	46.90	15.55	4.56	1.61	0.00
spinal cord - adult, donor10196	10181-103D1	77.08	25.01	6.65	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	110.79	17.35	3.15	2.37	0.00
spinal cord, adult, donor10258	10369-105F9	59.49	27.67	4.15	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	81.11	28.66	6.71	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	96.89	14.24	7.81	1.38	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	95.59	16.43	7.47	3.44	3.14
spleen, adult, pool1	10025-101D7	67.84	17.07	4.96	1.21	0.44
spleen, fetal, pool1	10044-101F8	22.17	7.63	1.35	0.64	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	22.36	8.18	1.97	0.52	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	63.23	27.15	3.99	1.52	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	46.48	19.92	5.59	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	44.57	20.72	4.69	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	44.57	14.86	3.94	1.58	1.69
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	54.64	19.91	5.08	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	97.31	7.19	5.08	0.42	0.42
stomach, fetal, donor1	10062-101H8	87.57	34.18	5.34	1.07	1.07
submaxillary gland, adult	10202-103F4	98.55	7.41	3.99	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	217.10	162.82	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	77.27	18.69	4.98	2.91	0.42
substantia nigra, adult, donor10258	10371-105G2	37.24	18.10	3.62	1.55	0.52
substantia nigra, newborn, donor10223	10358-105E7	57.23	8.48	4.95	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	44.94	19.03	6.42	1.83	0.23
temporal lobe, adult, pool1	10031-101E4	23.82	8.05	1.70	0.59	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	58.41	14.96	3.56	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	36.04	10.11	3.52	0.44	0.00
tenocyte, donor1	11763-123H8	77.85	10.47	2.09	1.05	0.00
tenocyte, donor2	11765-123I1	58.37	4.58	4.58	1.53	0.00
tenocyte, donor3	11768-123I4	74.13	8.90	3.71	1.85	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	127.64	39.26	8.33	3.40	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	53.03	21.27	2.93	0.92	0.15
teratocarcinoma cell line:PA-1	10807-111A6	71.75	33.79	5.42	1.86	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	41.51	17.52	4.70	2.67	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	55.59	28.36	6.43	1.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	45.26	6.65	2.29	1.42	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	40.06	14.01	4.89	4.23	1.63
testis, adult, pool1	10026-101D8	65.28	15.78	3.54	0.97	0.43
testis, adult, pool2	10096-102C6	30.22	23.01	1.80	1.80	0.00
thalamus - adult, donor10196	10168-103B6	66.24	44.16	1.10	2.21	0.00
thalamus, adult, donor10252	10154-103A1	82.52	20.32	3.75	1.56	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	64.66	38.49	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	51.55	16.30	2.47	0.99	0.00
thalamus, newborn, donor10223	10366-105F6	40.85	9.78	4.03	0.00	0.00
throat, adult	10209-103G2	89.63	14.23	6.49	3.00	0.75
throat, fetal, donor1	10061-101H7	79.22	9.75	3.66	1.52	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	115.26	14.31	6.36	1.59	0.40
thymus, adult, pool1	10027-101D9	49.41	26.15	3.28	2.09	0.00
thymus, fetal, pool1	10043-101F7	65.98	21.20	3.74	1.77	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	40.55	16.75	5.05	0.53	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	52.24	17.04	4.33	1.40	0.42
thyroid, adult, pool1	10028-101E1	98.35	15.49	3.73	2.33	0.28
thyroid, fetal, donor1	10060-101H6	56.69	17.93	2.37	2.64	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	12.32	0.00	0.00	0.00
tongue, adult	10203-103F5	99.08	11.16	6.98	3.49	0.23
tongue, fetal, donor1	10059-101H5	128.08	16.16	6.70	1.18	2.76
tonsil, adult, pool1	10047-101G2	38.37	12.12	2.60	0.70	0.10
trachea, adult, pool1	10029-101E2	64.29	10.72	3.84	1.31	0.08
trachea, fetal, donor1	10058-101H4	69.63	7.31	2.69	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	64.83	16.65	4.96	2.83	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	75.28	18.95	5.27	1.62	1.01
transitional-cell carcinoma cell line:JMSU1	10492-107B6	55.47	13.16	2.19	0.94	0.16
tridermal teratoma cell line:HGRT	10694-109G1	70.39	19.03	1.90	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	60.95	17.18	3.98	1.19	0.17
umbilical cord, fetal, donor1	10057-101H3	39.64	8.35	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	59.38	13.65	3.24	0.68	0.17
uterus, fetal, donor1	10055-101H1	83.96	8.70	5.12	0.51	0.00
vagina, adult	10204-103F6	84.01	3.23	0.65	0.65	0.65
vein, adult	10191-103E2	54.14	10.52	3.73	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	56.88	13.08	2.14	0.53	0.00